Search research articles
Contact Us
Filters
Showing results (291-300 of 7,541) with videos related to
Page
of 755
Sort By:
Nature Biotechnology
|
December 17, 2009
Making green
Cormac Sheridan
Medical Economics
|
January 17, 1978
A new malpractice shield for doctors who go bare
B Sheridan
Dynamis (Granada, Spain)
|
October 20, 2001
At birth: the modern state, modern medicine, and the royal midwife Louise Bourgeois in seventeenth-century France
B Sheridan
British Journal of Haematology
|
December 20, 2018
Comment on: type 1 cryoglobulinaemia leading to gangrene of the toes and ischaemic ulceration
Mathew Sheridan
Nature Biotechnology
|
March 7, 2018
First off-the-shelf mesenchymal stem cell therapy nears European approval
Cormac Sheridan
Nature Biotechnology
|
December 9, 2017
Ablynx's nanobody fragments go places antibodies cannot
Cormac Sheridan
BMJ (Clinical Research Ed.)
|
July 28, 2001
Kyoto protocol rescued in Bonn
K Sheridan
Nature Biotechnology
|
January 6, 2026
Now with oligos: antibody-oligonucleotide conjugates are the new drug modality to watch
Cormac Sheridan
Nature Biotechnology
|
July 27, 2021
Publisher Correction: Questions swirl around failures of disease-modifying Huntington's drugs
Cormac Sheridan
Nature Biotechnology
|
June 17, 2024
B cells as drug factories
Cormac Sheridan
Page
of 755
Search research articles
Search
Showing results (291-300 of 7,541) with videos related to
Sort By:
Page
of 755
Nature Biotechnology
|
December 17, 2009
Making green
Cormac Sheridan
Medical Economics
|
January 17, 1978
A new malpractice shield for doctors who go bare
B Sheridan
Dynamis (Granada, Spain)
|
October 20, 2001
At birth: the modern state, modern medicine, and the royal midwife Louise Bourgeois in seventeenth-century France
B Sheridan
British Journal of Haematology
|
December 20, 2018
Comment on: type 1 cryoglobulinaemia leading to gangrene of the toes and ischaemic ulceration
Mathew Sheridan
Nature Biotechnology
|
March 7, 2018
First off-the-shelf mesenchymal stem cell therapy nears European approval
Cormac Sheridan
Nature Biotechnology
|
December 9, 2017
Ablynx's nanobody fragments go places antibodies cannot
Cormac Sheridan
BMJ (Clinical Research Ed.)
|
July 28, 2001
Kyoto protocol rescued in Bonn
K Sheridan
Nature Biotechnology
|
January 6, 2026
Now with oligos: antibody-oligonucleotide conjugates are the new drug modality to watch
Cormac Sheridan
Nature Biotechnology
|
July 27, 2021
Publisher Correction: Questions swirl around failures of disease-modifying Huntington's drugs
Cormac Sheridan
Nature Biotechnology
|
June 17, 2024
B cells as drug factories
Cormac Sheridan
Page
of 755